Smoking Status, Body Mass Index, Health-Related Quality of Life, and Acceptance of Life With Illness in Stable Outpatients With COPD

Abstract

Smoking and obesity are important factors related to the etiology and clinical features of chronic obstructive pulmonary disease (COPD). The aim of this study was to carry out deeper analyses of the links between smoking status and body mass index as well as of the links between individual dimensions of health-related quality of life (QoL) and acceptance of life with disease in patients with COPD. Information about BMI, smoking status, clinical features of COPD, a COPD assessment test, and airflow obstruction indicators were obtained from 105 outpatients attending a pulmonary clinic. Analysis of covariance demonstrated that the subgroups of patients distinguished based on smoking status and BMI differed significantly in severity of Cough, Dyspnea, Limitation of daily activities, Lack of self-confidence, and Quality of sleep, independently of sociodemographic factors and clinical features of COPD. The results of our study suggest a certain path of the potential effects of obesity and smoking status on QoL. Risky health behaviors, such as smoking and at-risk body mass, only affect some aspects of health-related QoL.

Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life

“…Comparing our findings with results from previous literature is difficult as, to our knowledge, this is the first study to evaluate the association between BMI trajectories and HRQoL in COPD. Although solid literature is available for the association between cross-sectional BMI values and HRQoL [ 7 , 29 , 30 ], literature evaluating the association between BMI change and HRQoL in COPD is rare. An evaluation based on the Copenhagen City Heart Study concludes that weight gain > 3 BMI points in obese COPD patients is associated with increased mortality, but only in patients with severe COPD and not the rest [ 23 ].…”

Evidence Based Faktor yang Berhubungan Dengan Kualitas Hidup Pasien PPOK Stabil: A Systematic Review

“…Kualitas hidup pasien PPOK stabil dipengaruhi oleh banyak beberapa faktor. Faktor tersebut dikategorikan menjadi tanda gejala penyakit dan eksaserbasi (9),( 12),( 16),( 17),( 18),( 19),( 20), (21) , kapasitas latihan fungsional (9),( 13),( 14),( 17), (18) , psikologi (9),( 18),( 20),( 21), (22) , sosiodemografi (11),( 13),( 15),( 16), (17) , biomolekular (10) , komorbiditas (9),( 17), (20) , dan faal paru (9),( 16),( 17),( 20), (21) .…”

“…Status merokok memiliki hubungan negatif yaitu bukan perokok memiliki kualitas hidup yang lebih baik daripada perokok atau mantan perokok. Perokok dan mantan perokok menjadi pemicu rendahnya kualitas hidup yang berakhir pada gejala eksaserbasi PPOK (11) . Hubungan positif juga ditemukan pada indeks massa tubuh yang tinggi atau obesitas yang memiliki kualitas hidup lebih baik (11) , namun kontras bahwa indeks massa tubuh memiliki tinggi memiliki kualitas hidup rendah (17) .…”

“…Perokok dan mantan perokok menjadi pemicu rendahnya kualitas hidup yang berakhir pada gejala eksaserbasi PPOK (11) . Hubungan positif juga ditemukan pada indeks massa tubuh yang tinggi atau obesitas yang memiliki kualitas hidup lebih baik (11) , namun kontras bahwa indeks massa tubuh memiliki tinggi memiliki kualitas hidup rendah (17) . Sedangkan usia tua memiliki kualitas hidup yang meningkat (16) karena usia muda merasa kurang mampu menghadapi penyakit dan usia tua yang telah lama menderita PPOK merasa sudah bisa beradaptasi dengan hidupnya (13) .…”

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial

“…Smoking is one of the most prominent risk factors for COPD, and the prevalence of COPD is higher in current and former smokers than in nonsmokers [ 4 ]. Among patients with COPD, current smokers have a greater rate of decline in lung function than former smokers [ 5 , 6 ], and smoking also has an impact on COPD symptoms and health status [ 7 , 8 ]. Smoking cessation can reduce long-term mortality risk [ 9 ] and is therefore an important element of COPD management, along with pharmacological maintenance therapy for many patients [ 4 , 10 ].…”